Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.
Yao Y, Sui WW, Liao AJ, Wang W, Chen LJ, Chu XX, Bao L, Cen XN, Fu R, Liu H, Sun CY, Jin FY, Yan H, Wang LQ, Yuan CL, Gao GX, Gao D, Zhang JQ, He JX, Hu JD, Ma LM, Zhang L, Zhou DB, Zou DH, Li J. Yao Y, et al. Among authors: cen xn. Age Ageing. 2022 Jan 6;51(1):afab211. doi: 10.1093/ageing/afab211. Age Ageing. 2022. PMID: 34673897
Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUS.
Fu W, Li W, Hu J, An G, Wang Y, Fu C, Chen L, Jin J, Cen X, Ge Z, Cai Z, Niu T, Qi M, Gai X, Li Q, Liu W, Liu W, Yang X, Chen X, Lu J. Fu W, et al. Clin Lymphoma Myeloma Leuk. 2023 Jan;23(1):e51-e58. doi: 10.1016/j.clml.2022.10.007. Epub 2022 Oct 23. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36402700 Free article. Clinical Trial.
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China.
Wang W, Zhang W, Su LP, Liu LH, Gao YH, Wang QS, Su H, Song YQ, Zhang HL, Shen J, Jing HM, Wang SY, Cen XN, Liu H, Liu AC, Li ZJ, Luo JM, He JX, Wang JW, O'Connor OA, Zhou DB. Wang W, et al. Among authors: cen xn. Ann Hematol. 2024 Aug;103(8):3061-3069. doi: 10.1007/s00277-024-05708-w. Epub 2024 May 28. Ann Hematol. 2024. PMID: 38805037 Clinical Trial.
[Comparison of therapeutic effects of low-dose versus high-dose interferon alpha-2b treatment on chronic myelocytic leukemia: a prospective randomized study].
Du JW, Zhu P, Tian D, Dong ZR, Yang SL, Li SB, Tang YH, Liu H, Cen XN, Zhang Y, Zhu Q, Zhu YL, Yang Y, Wang DX, Wang Z, Cui H, Ma YG, Chen WM, Liu FQ, Ma J, Wang JW, Shen T, Da WM. Du JW, et al. Among authors: cen xn. Zhonghua Yi Xue Za Zhi. 2005 May 25;85(19):1305-9. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16029627 Clinical Trial. Chinese.
[Expression of CD56 and CD19 in Patients with Newly Diagnosed Multiple Myeloma and Their Relationship with Karyotypes and Prognosis].
Qiu Q, Zhu P, Wang MJ, Lu XZ, Dong YJ, Sun YH, Wang LH, Zhang Y, Bu DF, Wang WS, Liang ZY, Liu W, Qiu ZX, Ou JP, Cen XN. Qiu Q, et al. Among authors: cen xn. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Aug;24(4):1071-8. doi: 10.7534/j.issn.1009-2137.2016.04.021. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 27531777 Chinese.
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.
Zhong K, Shi Y, Gao Y, Zhang H, Zhang M, Zhang Q, Cen X, Xue M, Qin Y, Zhao Y, Zhang L, Liang R, Wang N, Xie Y, Yang Y, Liu A, Bao H, Wang J, Cao B, Zhang W, Zhang W. Zhong K, et al. BMC Cancer. 2023 Aug 11;23(1):746. doi: 10.1186/s12885-023-11268-5. BMC Cancer. 2023. PMID: 37568079 Free PMC article.
[Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
Wang CY, Ren HY, Qiu ZX, Wang Y, Cen XN, Wang LH, Wang MJ, Xu WL, Wang WS, Li Y, Dong YJ, Ou JP, Liang ZY, Liu W, Wang Q. Wang CY, et al. Among authors: cen xn. Zhonghua Xue Ye Xue Za Zhi. 2013 Aug;34(8):659-63. doi: 10.3760/cma.j.issn.0253-2727.2013.08.004. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23978015 Chinese.
[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].
Shi YK, Yang S, Han XH, Ma J, Ren HY, Cen XN, Zhou SY, Wang C, Jiang WQ, Huang HQ, Wang JM, Zhu J, Chen H, Han MZ, Huang H, Shen XM, Liu P, He XH. Shi YK, et al. Among authors: cen xn. Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):592-6. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20021946 Clinical Trial. Chinese.
62 results